All In Biotech

Free tool

FAERS Monitor: Eovist

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022090 or its brand name (Eovist, Gadoxetate Disodium). Reports on generic versions are filed under their own applications.

Reports

441

Serious

244

55% of reports

Hospitalization

30

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • rash160
  • pain155
  • paraesthesia154
  • arthralgia153
  • burning sensation153
  • hypoaesthesia153
  • muscle spasms153
  • gadolinium deposition disease152
  • injury152
  • asthenia150
  • confusional state150
  • fatigue150
  • inflammation150
  • mass147
  • anxiety80

Reports by year received

View as table
YearReports
20085
200916
201040
201147
201223
201319
201420
201514
201618
201714
201814
2019165
20207
20218
20225
202310
20248
20254
20264

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,718 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
gadolinium deposition diseaseSignal15218096.315394.71,981,315
massSignal147506.9443.772,988
inflammationSignal150139.0122.020,408
burning sensationSignal153104.391.715,568
injurySignal152103.390.815,321
hypoaesthesiaSignal15348.842.97,159
paraesthesiaSignal15446.741.16,891
confusional stateSignal15044.338.96,350
muscle spasmsSignal15339.835.05,793
astheniaSignal15019.016.72,590
arthralgiaSignal15317.615.42,419
rashSignal16017.515.52,526
anxietySignal8013.411.0919
painSignal15512.010.61,604
fatigueSignal1509.28.11,128

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.